Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products.
L A Juncos, … , S Arima, S Ito
L A Juncos, … , S Arima, S Ito
Published April 1, 1993
Citation Information: J Clin Invest. 1993;91(4):1374-1379. https://doi.org/10.1172/JCI116339.
View: Text | PDF
Research Article

Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products.

  • Text
  • PDF
Abstract

It has been suggested that platelet-activating factor (PAF) plays a prominent role in the control of glomerular hemodynamics in various physiological and pathological conditions. We examined the direct effect of PAF on rabbit glomerular afferent arterioles (Af-Arts) microperfused in vitro and tested whether endothelium-derived relaxing factor/nitric oxide (EDNO) and cyclooxygenase products are involved in its actions. In nanomolar concentrations PAF caused dose-dependent constriction of Af-Arts, with the maximum constriction being 34 +/- 10% at 4 x 10(-8) M (n = 9, P < 0.001). The constriction was blunted by cyclooxygenase inhibition (11 +/- 6%, n = 7, P < 0.05) but augmented by EDNO inhibition (76 +/- 14%, n = 8, P < 0.005). To study a possible vasodilator effect of PAF, Af-Arts were preconstricted with norepinephrine and increasing concentrations of PAF added to the lumen. At picomolar concentrations (lower than those that caused constriction), PAF produced dose-dependent vasodilation that was unaffected by cyclooxygenase inhibition but was abolished by EDNO synthesis inhibition. Both PAF-induced constriction and dilation of Af-Arts were blocked by a PAF receptor antagonist. This study demonstrates that PAF has a receptor-mediated biphasic effect on rabbit Af-Arts, dilating them at low concentrations while constricting them at higher concentrations. Our results suggest that PAF's vasodilator action may be due to production of EDNO, while its constrictor action is mediated at least in part through cyclooxygenase products.

Authors

L A Juncos, Y L Ren, S Arima, S Ito

×

Total citations by year

Year: 2020 2018 2016 2012 2008 2004 2003 2002 2000 1999 1998 1997 1996 1995 1994 Total
Citations: 1 1 1 1 2 1 2 2 3 1 3 4 3 2 1 28
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (28)

Title and authors Publication Year
The pathophysiological effects of Russell's viper (Daboia siamensis) venom and its fractions in the isolated perfused rabbit kidney model: A potential role for platelet activating factor
N Chaiyabutr, L Chanhome, T Vasaruchapong, P Laoungbua, O Khow, A Rungsipipat, V Sitprija
2020
Hypotensive effect of bi-potassium salt of 1-hexadecyl-2-methylcarbamoylphosphatidic acid in rats with renovascular hypertension
NY Khromova, SI Malekin, SA Gavrilova, SV Kotelevtsev, YV Kotelevtsev
2018
Nuclear localization of platelet-activating factor receptor controls retinal neovascularization
VK Bhosle, JC Rivera, TE Zhou, S Omri, M Sanchez, D Hamel, T Zhu, R Rouget, AA Rabea, X Hou, I Lahaie, A Ribeiro-da-Silva, S Chemtob
Cell Discovery 2016
Brenner and Rector's The Kidney
C Brugnara, KU Eckardt
Brenner and Rector's The Kidney 2012
Antihypertensive effects of crude extracts from leaves of Echinodorus grandiflorus
MA Lessa, CV Araújo, MA Kaplan, D Pimenta, MR Figueiredo, E Tibiriçá
Fundamental & Clinical Pharmacology 2008
Platelet-activating factor (PAF) increases NO production in human endothelial cells—real-time monitoring by DAR-4M AM
M Kikuchi, H Shirasaki, T Himi
Prostaglandins, Leukotrienes and Essential Fatty Acids 2008
Application of a TCA-precipitation method for the determination of 1-alkyl-sn-glycero-3-phosphate:Acetyl-CoA acetyltransferase in human renal tissue
TN Nomikos, C Iatrou, CA Demopoulos
Prostaglandins & Other Lipid Mediators 2004
Contributions of nitric oxide, EDHF, and EETs to endothelium-dependent relaxation in renal afferent arterioles
D Wang, LJ Borrego-Conde, JR Falck, KK Sharma, CS Wilcox, JG Umans
Kidney International 2003
Platelet-activating factor and solute transport processes in the kidney
RK Handa, JW Strandhoy, CE Giammattei, SE Handa
American journal of physiology. Renal physiology 2003
Nitric oxide attenuates platelet-activating factor-induced nasal airway plasma extravasation in healthy subjects
M Maniscalco, G Ferrara, L Carratu, M Sofia
European Journal of Clinical Investigation 2002
Vasodilator Action of Angiotensin-(1-7) on Isolated Rabbit Afferent Arterioles
YL Ren, JL Garvin, OA Carretero
Hypertension 2002
The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide
M Maniscalco, M Sofia, S Faraone, L Carratù
Allergy 2000
Activation of Platelet-activating Factor (PAF) Receptor Stimulates Nitric Oxide (NO) Release Via Protein Kinase C-α in HEC-1B Human Endometrial Epithelial Cell Line
S Dearn, M Rahman, A Lewis, Z Ahmed, MC Eggo, AS Ahmed
Molecular Medicine 2000
Nitric Oxide and the Regulation of the Peripheral Circulation
PJ Kadowitz, DB McNamara
2000
Potential role of platelet activating factor in acute renal failure
JM Lopez-Novoa
Kidney International 1999
Nitric oxide mediates plateletactivating factor stimulatory action on uterine prostaglandin production
MA Chaud, AM Franchi, MB Astrada, MF Gimeno
Prostaglandins, Leukotrienes and Essential Fatty Acids 1998
Plasma and urinary platelet activating factor concentrations and leukotriene releasing activity of leukocytes in steroid sensitive nephrotic syndrome of childhood
A Hüseyinov, M Kantar, S Mir, I Coker, C Kabasakal, A Cura
Pediatrics International 1998
Localization, quantification, and activation of platelet-activating factor receptor in human endometrium during the menstrual cycle: PAF stimulates NO, VEGF, and FAK pp125
A Ahmed, S Dearn, M Shams, XF Li, RK Sangha, M Rola-pleszczynski, J Jiang
The FASEB Journal 1998
The acute increases in vasomotor tone and blood pressure induced by carotid artery occlusion are modulated by platelet-activating factor (PAF) independently of nitric oxide release
RA Lopes-Martins, V Estato, CV Araújo, M Catelli, RS Cordeiro, E Tibiriçá
Journal of Lipid Mediators and Cell Signalling 1997
Role of superoxide and nitric oxide in platelet-activating factor-induced acute lung injury, hypotension, and mortality in rats:
T Yoshikawa, H Takano, H Yamamoto, Y Nakahashi, T Yamaguchi, T Arimoto, M Kondo
Critical Care Medicine 1997
Nitric Oxide and the Kidney
MS Goligorsky, SS Gross
1997
Platelets and Their Factors
F von Bruchhausen, U Walter
1997
Renal ischaemia-reperfusion injury
SC Weight, PR Bell, ML Nicholson
British Journal of Surgery 1996
Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs
K Noguchi, T Matsuzaki, N Shiroma, Y Ojiri, M Sakanashi
British Journal of Pharmacology 1996
Renal ischaemia-reperfusion injury: RENAL ISCHAEMIA-REPERFUSION INJURY
SC Weight, PR Bell, ML Nicholson
The British journal of surgery 1996
Glomerular actions of nitric oxide
L Raij, C Baylis
Kidney International 1995
High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles
S Arima, S Ito, K Omata, K Takeuchi, K Abe
Kidney International 1995
Cyclic guanosine monophosphate is the mediator of platelet-activating factor inhibition on transport by the mouse kidney thick ascending limb
F Néant, M Imbert-Teboul, C Bailly
Journal of Clinical Investigation 1994

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts